How Is Thyroid Cancer Diagnosed
For most people, the path toward a thyroid cancer diagnosis starts with a small, unexpected discovery. You might feel a lump while buttoning a collar or fastening a necklace. Your doctor might feel it during a routine physical exam. Or, most commonly of all, a nodule (an abnormal growth of cells that forms a lump within the thyroid gland) might be spotted by accident on a CT scan, MRI, or ultrasound done for a completely different reason, such as a car accident evaluation or a carotid artery check. Thyroid nodules rarely cause pain or other symptoms on their own, so finding one usually depends on someone looking closely at the right place, whether that is your own hand, your doctor's exam, or a radiologist reading a scan.
Once a nodule is found, you are usually not managed by just one doctor.
Your primary care doctor often makes the first discovery and orders initial blood work.
From there, care commonly moves to an endocrinologist (a doctor who specializes in hormone-producing glands like the thyroid), who directs the workup and interprets results in context.
A radiologist reads your ultrasound and any other imaging.
If a biopsy is needed, either the endocrinologist or a radiologist may perform it, and a pathologist (a doctor who examines cells and tissue under a microscope) reads the sample.
If surgery becomes necessary, an endocrine surgeon, a surgeon with specific training in thyroid and parathyroid operations, takes over that part of your care.
This team approach is normal and is a sign of careful, thorough evaluation rather than a cause for alarm.
Here is the most important fact to hold onto as you start this process: the large majority of thyroid nodules are not cancer. Research summarized by the American Thyroid Association shows that by age 60, about half of all people have a thyroid nodule that can be found by exam or imaging, and more than 90 percent of those nodules turn out to be benign (noncancerous). Finding a nodule is the beginning of a careful evaluation, not a diagnosis. The goal of everything described in this guide is to sort out, as efficiently and gently as possible, which small number of nodules need further action and which simply need to be watched or can be left alone.
That said, it is completely normal to feel anxious while you wait for answers. Even when the odds favor a benign result, the uncertainty of "we need to check this out" is stressful. It may help to understand exactly what each test does and why your care team is ordering it, which is the purpose of this guide. If you want more background first, you may find it helpful to read about thyroid cancer symptoms and risk factors for thyroid cancer before diving into the testing process itself.
It is also worth knowing up front that thyroid cancer is not one single disease. Most cases are papillary or follicular thyroid carcinoma, together called differentiated thyroid cancer (DTC), which behave similarly and generally have a very good outlook. A smaller number of cases are medullary thyroid carcinoma (MTC), which arises from different cells and is tested for differently, as explained below. Anaplastic thyroid carcinoma (ATC) is rare and fast-growing, and is diagnosed and managed on an urgent basis. Most of this guide describes the standard workup used for the common situation, a nodule that might be DTC, with clear signposts wherever MTC or ATC testing diverges from that path.
What Tests Are Used to Diagnose Thyroid Cancer?
There is no single test that proves whether a thyroid nodule is cancer. Instead, your care team builds a picture using a combination of exam findings, blood work, imaging, and, in most cases, a biopsy. Each test below adds a piece of information, and together they guide the decision about whether you need surgery, more monitoring, or nothing further at all.
Medical history and physical exam of the neck
The workup usually begins with your doctor asking about your health history, including any past radiation exposure (especially to the head or neck in childhood), family history of thyroid disease or thyroid cancer, and any symptoms such as voice changes, trouble swallowing, or a feeling of pressure in the neck. Your doctor will then feel your neck, checking the size, texture, and mobility of the thyroid gland and any nodule, as well as feeling for enlarged lymph nodes nearby.
This part of the exam is quick, does not hurt, and simply involves your doctor pressing gently on your neck while you swallow. A firm, fixed nodule, one that is very large, or nearby enlarged lymph nodes can raise concern and lead to a more urgent workup, but many people with these findings still turn out to have benign conditions. The exam alone cannot tell your doctor whether a nodule is cancer, which is why blood tests and imaging come next.
Thyroid function blood tests (TSH and sometimes free T4)
Your doctor will likely order a blood test to measure thyroid-stimulating hormone (TSH), a hormone made by the pituitary gland in the brain that tells your thyroid how much thyroid hormone to make. Sometimes free T4 (a measure of active thyroid hormone in your blood) is checked as well. This is a routine blood draw from a vein in your arm and does not require fasting.
It is important to understand what this test is, and is not, checking for. A cancer workup is not primarily about whether your hormone levels are normal or abnormal. In fact, the American Thyroid Association notes that thyroid function tests are usually normal even when cancer is present in a nodule, because most thyroid nodules, cancerous or not, do not make extra hormone. TSH testing still matters for two reasons. First, an abnormal TSH can point toward a different, often benign explanation for a nodule, such as an overactive nodule that makes its own hormone and rarely needs a biopsy. Second, TSH helps your doctor decide which imaging test to order next. A normal TSH does not rule out cancer, and a normal TSH result should not be read as reassurance on its own.
Thyroid ultrasound and risk stratification
Ultrasound is the single most useful imaging test for evaluating a thyroid nodule. It uses sound waves, not radiation, to create a detailed picture of the thyroid and any nodules within it. During the test, you lie on your back with your neck slightly extended while a technician or radiologist moves a small handheld device (a transducer) over your neck after applying a clear gel. It is painless, takes about 15 to 30 minutes, and involves no needles or preparation.
Ultrasound tells your doctor a great deal: the exact size of a nodule, whether it is solid or filled with fluid (cystic), how many nodules are present, and whether nearby lymph nodes look enlarged or abnormal. Radiologists also look for specific features that are more common in cancerous nodules, such as a very dark (hypoechoic) appearance, irregular or poorly defined edges, tiny calcium deposits called microcalcifications, a shape that is taller than it is wide, and extension beyond the thyroid capsule.
To organize these features into a consistent risk estimate, many radiologists use a formal risk stratification system, most commonly the American College of Radiology Thyroid Imaging Reporting and Data System, known as TI-RADS. TI-RADS scores a nodule on five categories: composition, echogenicity (how dark or light the tissue appears), shape, margin, and the presence of echogenic foci (bright spots that can represent calcifications), and adds up points to assign a risk level, from TR1 (benign-appearing) to TR5 (highly suspicious). That risk level, combined with the nodule's size, is what determines whether your doctor recommends a biopsy, ultrasound monitoring, or no further action. TI-RADS is a tool for describing risk, not a diagnosis, and only a biopsy can tell you for certain whether a nodule is cancer.
Fine needle aspiration (FNA) biopsy
If your ultrasound findings suggest a biopsy is worthwhile, the standard next step is a fine needle aspiration (FNA) biopsy. Despite the word "surgery" sometimes attached to biopsies in people's minds, this is a simple procedure, usually done in an office or clinic in under 30 minutes.
During an FNA, a radiologist or endocrinologist uses ultrasound to guide a very thin, hollow needle directly into the nodule. Local numbing medicine is sometimes used, but many patients do not need it at all because the needle is so fine. The doctor withdraws small samples of cells and a bit of fluid, usually repeating this several times from different parts of the nodule to gather enough tissue. Most patients describe the sensation as a brief pressure or pinch rather than significant pain. You can typically return to normal activity right away, without stitches or even a bandage. Blood-thinning medications sometimes need to be paused beforehand, so tell your doctor about everything you take.
The cell samples go to a pathologist, who reports the results using a standard classification called the Bethesda System for Reporting Thyroid Cytopathology. In plain terms, the six Bethesda categories are:
Nondiagnostic: Not enough cells were collected to make a reliable read. This happens in a small share of biopsies, often with cystic nodules, and usually means repeating the FNA.
Benign: The most common result, seen in the majority of biopsies. The risk that a benign reading is actually cancer is low, generally under 3 in 100 cases, and surgery is not usually needed.
Atypia of undetermined significance (also called follicular lesion of undetermined significance): The cells show some unusual features that do not clearly point to benign or cancerous. This is a genuinely gray zone, and your doctor may recommend repeating the FNA, molecular testing, or continued monitoring.
Follicular neoplasm (or suspicious for a follicular neoplasm): The cells look like they could form a growth, but FNA cannot always tell a benign follicular adenoma from a follicular cancer because that distinction depends on whether the growth has invaded through its capsule, something only visible after surgical removal. This category often leads to a discussion about molecular testing or surgery.
Suspicious for malignancy: Some, but not all, features of cancer are present. This category carries a meaningfully higher cancer risk and usually leads to surgery.
Malignant: The cells clearly show cancer. Papillary thyroid carcinoma is the most common finding in this category, though medullary and anaplastic thyroid cancer can also be diagnosed this way, as can cancer that has spread to the thyroid from elsewhere.
If your report uses different wording, such as "AUS/FLUS" or "Bethesda III," you can ask your doctor to translate it into these plain language categories so you understand exactly where your result falls.
Molecular testing on FNA samples
When an FNA comes back indeterminate (atypia of undetermined significance or follicular neoplasm), roughly a quarter or more of biopsies fall into this gray zone; your doctor may recommend molecular testing on the same biopsy sample. These tests, sold under names such as Afirma or ThyroSeq, examine the genes and gene activity inside the collected cells to help estimate the odds that a nodule is cancerous.
In plain terms, these tests work as a second layer of information on top of the biopsy. A result that comes back "benign-like" or with a low risk score makes surgery less likely to be needed and supports careful monitoring instead. A result that comes back "suspicious" raises the likelihood of cancer and often supports moving forward with surgery. No molecular test is perfect, and your care team will weigh the result alongside your ultrasound findings, nodule size, and personal preferences rather than relying on it alone. The main value of these tests is helping you and your doctor avoid unnecessary diagnostic surgery when a nodule is very likely benign, while still catching nodules that need to come out.
Calcitonin and CEA blood tests (used when medullary thyroid cancer is suspected)
Medullary thyroid cancer works differently from the papillary and follicular thyroid cancers described above, and its workup includes tests that are not part of the routine nodule evaluation. If your FNA results are suspicious for or diagnostic of medullary thyroid carcinoma, or if you have a family history of it, your doctor will order blood tests for calcitonin (a hormone made by the C cells of the thyroid, which are the cells that give rise to MTC) and carcinoembryonic antigen (CEA, a protein that can be elevated in several conditions but is useful here as a tumor marker). Both are typically elevated when medullary thyroid cancer is present. These tests are drawn like any other blood test and require no special preparation. They help confirm an MTC diagnosis before surgery, guide how extensive that surgery needs to be, and later serve as tumor markers to watch for recurrence.
RET genetic testing for medullary thyroid cancer
If you are diagnosed with medullary thyroid carcinoma, genetic testing for mutations in the RET gene is a standard, actionable recommendation, not an optional extra. About one in four cases of MTC is hereditary, caused by a mutation present in every cell of the body (a germline mutation), and can occur as part of multiple endocrine neoplasia type 2A (MEN2A), type 2B (MEN2B), or familial MTC without other associated tumors. The rest are sporadic, meaning the mutation is limited to the tumor and is not inherited. A simple blood test for RET mutations tells you and your care team which situation you are in. If a hereditary mutation is found, first-degree relatives, meaning parents, siblings, and children, can be offered testing too, since finding a mutation early in a family member allows for close monitoring or preventive treatment before cancer develops. A specialist familiar with MEN2 will set the specific plan, since recommended monitoring and timing depend on which RET mutation is found.
Imaging for staging
If cancer is confirmed, your doctor will use additional imaging to understand how far it may have spread, a process called staging. Neck ultrasound, the same painless test described above, is typically used first to check nearby lymph nodes for signs of spread. In select cases, your doctor may add other imaging: a CT scan (a series of detailed X-ray images) to look at the extent of disease in the neck or chest, an MRI (which uses magnets and radio waves rather than radiation), especially when contrast dye containing iodine needs to be avoided ahead of possible radioactive iodine treatment, or a PET scan (which highlights areas of higher metabolic activity) if there is concern the cancer does not absorb iodine well. Not everyone needs every one of these tests. Your doctor will choose based on your specific findings. You can read more about how these results translate into a formal stage in our guide to thyroid cancer stages.
Laryngoscopy to check vocal cord function
Before surgery, and especially if you have noticed hoarseness or other voice changes, your doctor may perform a laryngoscopy. This is a short procedure in which a doctor looks at your vocal cords using either a small mirror or a thin, flexible tube with a light and lens (a laryngoscope), usually passed gently through the nose. It typically takes just a few minutes in the office, and while it can feel unusual, it is not typically painful. This test checks whether your vocal cords are moving normally, since a thyroid tumor can occasionally press on or involve the nerve that controls them, called the recurrent laryngeal nerve. Knowing your vocal cord function before surgery gives your surgical team an important baseline and helps them plan the safest operation.
What About a Nodule Found by Accident?
Many people reading this guide did not go looking for a thyroid problem at all. A nodule showed up as a side finding, sometimes called an incidentaloma, on a CT scan of the chest, an MRI of the spine, a carotid ultrasound, or even a PET scan done for an unrelated reason. This is extremely common. Research on thyroid nodules shows that with modern imaging, nodules can be found in a large share of adults who are scanned for any reason, and the vast majority of these incidental findings are benign.
The key question after an incidental nodule is found is not "is this cancer" but "does this need a biopsy at all?" That decision depends mainly on two things: how large the nodule is and what it looks like on a dedicated thyroid ultrasound. A small nodule with reassuring features on ultrasound, using a system like TI-RADS as described above, often needs no biopsy at all, just documentation and, in some cases, a follow-up ultrasound. Larger nodules, or those with suspicious features even at a smaller size, are more likely to be recommended for FNA.
If your nodule does not need an immediate biopsy, your doctor will usually recommend periodic monitoring with ultrasound, commonly checked again somewhere in the range of 6 months to 2 years depending on the nodule's size and appearance, with longer intervals over time if nothing changes. This surveillance approach is a deliberate, evidence-based strategy, not a delay in care. It exists because for most low-risk, small, or reassuring-looking nodules, waiting and watching carries very little risk, while it spares people unnecessary biopsies and surgery for growths that were never going to cause a problem. If you feel anxious about "just watching," it can help to know that your doctor has a specific plan and specific triggers, such as growth or a change in ultrasound features, that would prompt further testing.
What Happens After Your Test Results Come Back?
If your tests confirm thyroid cancer, the next step is staging, the process of determining how much cancer is present and whether it has spread, described above and in more detail in our guide to thyroid cancer stages. For differentiated thyroid cancer, staging uniquely takes your age into account, since the outlook differs for people younger than 55 compared with those 55 and older at diagnosis, even with similar tumor findings. Medullary and anaplastic thyroid cancer are staged using their own separate systems, reflecting how differently they behave.
From here, your care usually involves a multidisciplinary team, meaning an endocrinologist, an endocrine surgeon, a pathologist, and sometimes a radiation oncologist or medical oncologist working together to plan your treatment. You can read about the treatment options this team may discuss in our guide to thyroid cancer treatment.
Surgeon experience genuinely matters for thyroid cancer outcomes. Surgeons and centers that perform a high volume of thyroid operations tend to have lower rates of complications, such as damage to the parathyroid glands or the nerves that control your voice. It is entirely reasonable to ask how many thyroid surgeries a surgeon performs each year, and to seek out an experienced thyroid or endocrine surgeon, even if that means traveling or waiting a bit longer for an appointment.
It is also reasonable, and often wise, to get a second opinion, particularly if your biopsy result was indeterminate, unusual, or if anything about your case does not feel fully settled. This can include asking for your pathology slides to be reviewed by a second pathologist at a high-volume thyroid center, since cytology interpretation involves some judgment and experienced eyes can catch things a first read might miss. Bringing a written list of questions to these appointments can help you make the most of the time. Our guide on questions to ask about thyroid cancer offers a helpful starting list.
Finally, if you are diagnosed with medullary thyroid carcinoma, genetic counseling should be part of your next steps, not an afterthought. A genetic counselor can help you understand your RET test result, what it means for your treatment, and what it means, or does not mean, for your family members. Whatever type of thyroid cancer you are facing, remember that these decisions are best made together with your care team, based on your specific pathology, imaging, and personal circumstances. This guide can help you understand the process, but it cannot replace a conversation with the doctors who know your case.
